MTVA Price / Book | METAVIA INC.

METAVIA INC. (MTVA) Price / Book

2026-09-03: Price/Book Ratio 1.77.
2026-06-30: Price/Book Ratio 1.38.
2026-03-31: Price/Book Ratio 0.68.
2025-12-31: Price/Book Ratio 3.64.

Historical market capitalization divided by filed shareholder equity.

Available history: 2016-09-30 to 2026-09-03
Data captured: 2026-09-04

Historical Price/Book Ratio

Date	Price/Book Ratio
2026-09-03	1.77
2026-06-30	1.38
2026-03-31	0.68
2025-12-31	3.64
2025-09-30	39.55
2025-06-30	17.78
2025-03-31	33.47
2024-12-31	2.21
2024-09-30	23.18
2024-06-30	23.11
2024-03-31	21.91
2023-12-31	11.96
2023-09-30	74.7
2023-06-30	58.37
2023-03-31	82.8
2022-12-31	9.24
2022-09-30	180.3
2022-06-30	3,824.95
2022-03-31	5,322.7
2021-12-31	196.09
2021-09-30	35,732.47
2021-06-30	20,564.6
2021-03-31	19,583.34
2020-12-31	37,851.25
2020-09-30	25,639.46
2020-06-30	28,295.76
2020-03-31	74,327.45
2019-12-31	29,302.94
2018-09-30	178,708.68
2018-06-30	636,084.52
2018-03-31	293,752.97
2017-12-31	223,025,929.34
2017-09-30	670,109.29
2017-06-30	505,420.11
2017-03-31	290,295.64
2016-12-31	232,493.25
2016-09-30	247,564.04

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
KALA BIO, Inc. (KALA)	United States	$0.011B	-3.33
Moleculin Biotech, Inc. (MBRX)	United States	$0.011B
Theriva Biologics, Inc. (TOVX)	United States	$0.011B
Azitra, Inc. (AZTR)	United States	$0.010B	-0.81
Dare Bioscience, Inc. (DARE)	United States	$0.011B
Medicus Pharma Ltd. (MDCX)		$0.010B
KIORA PHARMACEUTICALS INC (KPRX)	United States	$0.012B
Scienture Holdings, Inc. (SCNX)	United States	$0.012B	-0.38
Aprea Therapeutics, Inc. (APRE)	United States	$0.010B	-0.78
Phio Pharmaceuticals Corp. (PHIO)	United States	$0.012B	-0.92